Interstitial Lung Disease Clinical Trials in Boston, Massachusetts

4 studies are recruiting for interstitial lung disease in Boston, Massachusetts right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Advanced Imaging to Assess the Effect of Immunosuppression on Progressive Fibrosis

    The purpose of this study is to investigate how immunosuppression treatment affects measurements of active collagen deposition using [68Ga]CBP8 positron emission tomography (PET) and tissue injury using dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) in individuals with non-idiopathi…

    Stage
    Phase 2
    Ages
    18 to 80
    Site
    Massachusetts General Hospital, Boston, Massachusetts
    Run by
    Peter Caravan

    See if you can join NCT07572383 on ClinicalTrials.gov

  2. Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

    Study RIN-PF-305 is designed to evaluate the safety and efficacy of inhaled treprostinil in subjects with progressive pulmonary fibrosis (PPF) over a 52-week period.

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Tufts Medical Center, Boston, Massachusetts
    Locations
    165 in total
    Run by
    United Therapeutics

    See if you can join NCT05943535 on ClinicalTrials.gov

  3. An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

    Study LTI-401 is an open-label, multicenter study which will evaluate the safety and tolerability of LIQ861 in subjects who have WHO Group 1 \& 3 PH.

    Stage
    Not phased
    Ages
    18 to 80
    Site
    Tufts Medical Center, Boston, Massachusetts
    Locations
    23 in total
    Run by
    Liquidia Technologies, Inc.

    See if you can join NCT06129240 on ClinicalTrials.gov

  4. Collagen-targeted PET Imaging for Early Interstitial Lung Disease

    The goal of this study is to investigate the ability of [68Ga]CBP8 to detect collagen deposition in early interstitial lung disease.

    Stage
    Phase 2
    Ages
    40 and older
    Site
    Massachusetts General Hospital, Boston, Massachusetts
    Run by
    Massachusetts General Hospital

    See if you can join NCT05417776 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.